Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure

Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure

Bibliographic Details
Main Authors:	Langereis, Eveline J, Borgo, Andrea, Crushell, Ellen, Harmatz, Paul R, van Hasselt, Peter M, Jones, Simon A, Kelly, Paula M, Lampe, Christina, van der Lee, Johanna H, Odent, Thierry, Sakkers, Ralph, Scarpa, Maurizio, Schafroth, Matthias U, Struijs, Peter A, Valayannopoulos, Vassili, White, Klane K, Wijburg, Frits A
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852175/

Similar Items

An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life
by: Kingma, Sandra DK, et al.
Published: (2013)

Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
by: Valstar, Marlies J, et al.
Published: (2011)

Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management
by: Solanki, Guirish A., et al.
Published: (2013)

Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
by: Braunlin, Elizabeth A., et al.
Published: (2011)

Anaesthesia and airway management in mucopolysaccharidosis
by: Walker, Robert, et al.
Published: (2012)

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study
by: Hendriksz, Christian J., et al.
Published: (2014)

Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome
by: Pal, Abhijit Ricky, et al.
Published: (2015)

Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure
by: de Ru, Minke H, et al.
Published: (2011)

Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry
by: D’Aco, Kristin, et al.
Published: (2012)

Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder
by: Wijburg, Frits A, et al.
Published: (2013)

Respiratory and sleep disorders in mucopolysaccharidosis
by: Berger, Kenneth I., et al.
Published: (2012)

Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI
by: Harmatz, Paul R., et al.
Published: (2013)

Diagnosing mucopolysaccharidosis IVA
by: Wood, Timothy C., et al.
Published: (2013)

Pregnancy in patients with mucopolysaccharidosis: a case series
by: Stewart, Fiona J., et al.
Published: (2016)

Open issues in Mucopolysaccharidosis type I-Hurler
by: Rossella Parini, et al.
Published: (2017-06-01)

Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux–Lamy syndrome): under-recognized and challenging to diagnose
by: Lachman, Ralph S., et al.
Published: (2014)

Clinical course of sly syndrome (mucopolysaccharidosis type VII)
by: Montaño, Adriana M, et al.
Published: (2016)

PReS-FINAL-2244: Ultrasound examination reveals typical alterations in joints of mucopolysaccharidosis (MPS) patients
by: Karabul, N, et al.
Published: (2013)

Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y
by: Jones, Simon A., et al.
Published: (2015)

Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome)
by: Kampmann, Christoph, et al.
Published: (2016)

Osteoarthropathy in mucopolysaccharidosis type II
by: NASCU, IOANA, et al.
Published: (2013)

From hypertransaminasemia to mucopolysaccharidosis IIIA
by: Krawiec, Paulina, et al.
Published: (2014)

Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I
by: Dickson, P.I., et al.
Published: (2015)

Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB
by: Meijer, O. L. M., et al.
Published: (2016)

Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issues
by: Hendriksz, Christian J., et al.
Published: (2016)

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA
by: Anson, Donald S, et al.
Published: (2007)

Severe tracheal and bronchial collapse in adults with type II mucopolysaccharidosis
by: Rutten, M., et al.
Published: (2016)

Mucopolysaccharidosis VI in cats – clarification regarding genetic testing
by: Lyons, Leslie A., et al.
Published: (2016)

Bone mineral density in mucopolysaccharidosis IVB
by: Kubaski, Francyne, et al.
Published: (2016)

Atypical presentation of mucopolysaccharidosis type IVA
by: Rush, Eric T.
Published: (2016)

Role of elosulfase alfa in mucopolysaccharidosis IVA
by: Regier, Debra S, et al.
Published: (2016)

Diagnostic and treatment strategies in mucopolysaccharidosis VI
by: Vairo, Filippo, et al.
Published: (2015)

Immunological evaluation of patients with mucopolysaccharidosis (MPS)
by: Aranda, Carolina, et al.
Published: (2015)

The evaluation of the disease advancement in patients with mucopolysaccharidosis
by: Opoka-Winiarska, Violetta
Published: (2014)

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
by: Wraith, J. Edmond, et al.
Published: (2007)

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease
by: Scarpa, Maurizio, et al.
Published: (2011)

Airway-Related Symptoms and Surgeries in Patients With Mucopolysaccharidosis I
by: Arn, Pamela, et al.
Published: (2015)

Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy
by: Braunlin, E., et al.
Published: (2012)

Amputation and rotationplasty in children with limb deficiencies: current concepts
by: Sakkers, Ralph, et al.
Published: (2016)

Arterial Pathology in Canine Mucopolysaccharidosis-I and Response to Therapy
by: Lyons, Jeremiah A., et al.
Published: (2011)